Letters to the Editor

Raheja RK Bharwani I Penetrante AE . Efficacy of risperidone for behavioral disorders in the elderly: A clinical observation. J Geriatr Psychiatry Neurol 1995;8:159–61.

Naranjo CA Herrmann N Mittmann N Bremner KE . Recent advances in geriatric psychopharmacology. Drugs Aging 1995;7:184–202.

Chen B Cardasis W . Delirium induced by lithium and risperidone combination. Am J Psychiatry 1996;153:1233–4.

Benazzi F . Venlafaxine withdrawal symptoms [letter]. Can J Psychiatry 1996;41:487.

Coupland NJ Bell CJ Potokar JP . Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 1996;16:356–62.

Malik K . Nefazodone: Structure, mode of action and pharmacokinetics. J of Psychopharmacol 1996;10(1 Suppl):1S–4S.

Lucki I . Serotonin receptor specificity in anxiety disorders. J Clin Psychiatry 1996;57(6 Suppl):5S–10S.

Nemeroff CB Lindsay DeVane C Pollock BC . Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996;153:311–20.

Weiden P Aquila R Standard J . Atypical antipsychotic drugs and long term outcome in schizophrenia. J Clin Psychopharmacol 1996;57(11 Suppl): 53S–60S.

Borison R . Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics. J Clin Psychopharmacol 1995;15(1 Suppl):24S–29S.

Casey D . Side effects profiles of new antipsychotic agents. J Clin Psychopharmacol 1996;57(11 Suppl):40S–45S.

Tamminga CA Lahti AC . The new generation of antipsychotic drugs. Int Clin Psychopharmacol 1996;11(2 Suppl):73S–76S.

Tollefson G Beasley C Tran P Street J Krueger J , Tamura R, and others. Olanzapine versus Haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial. Am J Psychiatry 1997;154:457–65.

Kane J Honigfeld G Singer J , Meltzer H, and the Clozaril Collaborative Study Group. Clozapine for the treatment resistant schizophrenic: A double blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789–96.

Marder S . Management of treatment-resistant patients with schizophrenia. J Clin Psychiatry 1996;57(11 Suppl):26S–30S.

Tollefson GD Beasley CM Jr Tran PV Street JS Knieger JA , Tamura RN, and others. Olanzapine versus Haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial. Am J Psychiatry 1997;154:457–65.

Meltzer HY Goode DJ Schyve PM Young M Fang VS . Effect of clozapine on human serum prolactin levels. Am J Psychiatry 1979;136:1550–5.

Waldman MD Safferman AZ . Pregnancy and clozapine. Am J Psychiatry 1993;150:168–9.

Kaplan B Modai I Staler M Kitai E Valevski A Weizman A . Clozapine treatment and risk of unplanned pregnancy. J Am Board Fam Pract 1995;8:239–41.

Tolis G Friesen HG . Prolactin and human reproduction. Can Med Assoc J 1976;115:709–11.

Andreasen NC . Negative symptoms in schizophrenia: Definition and reliability. Arch Gen Psychiatry 1982;39:784–8.

Bode L Riegel S Ludwig H Amsterdam W Lange W Koprowski H . Borna disease virus-specific antibodies in patients with HIV infection and with mental disorders. Lancet 1988;2:689.

de la Torre JC . Molecular biology of Borna disease virus: Prototype of a new group of animal virus. J Virol 1994;68:7669–75.

Kishi M Nakaya T Nakamura Y Zhong Q Ikeda K , Senjo M, and others. Demonstration of Borna disease virus RNA in human peripheral blood mononuclear cells. FEBS Lett 1995;364:293–7.

Iwahashi K Watanabe M Nakamura K Fujiwara Y Isoshima G , Suwaki H, and others. The relationship between borna disease virus and schizophrenia. Clinical Psychiatry 1997;39:1275–9.